It falls under the category of myeloid/lymphoid neoplasms with eosinophilia and rearrangements involving PDGFRA, PDGFRB, FGFR1, or PCM1-JAK2, as classified in the 2016 World Health Organization classification of myeloid neoplasms [4]. Here, PDGFRA is linked to Increased total eosinophil count.